Results 51 to 60 of about 459,727 (225)

Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual influenza vaccination, the Advisory Committee on Immunization Practices recommends tetanus ...
Linda M. Niccolai, Caitlin E. Hansen
doaj   +1 more source

Immunogenicity of the 9‐Valent Human Papillomavirus Vaccine in Occupationally‐Exposed Adults

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 6, December 2026.
ABSTRACT Objective HPV is the most common sexually transmitted infection and has a well‐established role in the pathogenesis of recurrent respiratory papillomatosis (RRP) and oropharyngeal squamous cell carcinoma (OPSCC). HPV DNA is detectable in surgical smoke, and case reports have linked occupational exposure to laryngeal papillomatosis in ...
Colleen M. Schinderle Thurber   +2 more
wiley   +1 more source

Unusual Presentation of Left‐Sided Bilothorax Following Spleen Laceration: A Case Without Biliary Tree Injury

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
We report a rare case of left‐sided bilothorax in a patient who had spleen laceration and hemoperitoneum after blunt abdominal trauma without any biliary tree injury. A high index of clinical suspicion is important to identify this underdiagnosed entity.
Thanuja Reddipilli   +3 more
wiley   +1 more source

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond

open access: yesHuman Vaccines & Immunotherapeutics
Wide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson   +7 more
doaj   +1 more source

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

open access: yesEmerging Infectious Diseases, 2017
In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended.
Heidi M. Soeters   +10 more
doaj   +1 more source

Management of Refractory Thymoma‐Associated Myasthenia Gravis With Sequential FcRn Antagonist and Complement Inhibition Combined With Resection of Pleural Dissemination

open access: yesNeurology and Clinical Neuroscience, Volume 14, Issue 6, Page 497-499, November 2026.
ABSTRACT Myasthenia gravis (MG) associated with disseminated thymoma is often refractory to conventional treatments due to continuous autoantibody production. The optimal treatment strategy, particularly the combination of complement component 5 (C5) inhibitor, neonatal Fc receptor (FcRn) antagonist, and surgical resection in thymoma‐associated ...
Hiroyuki Takenaka   +3 more
wiley   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2370-2379, November 2026.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.

open access: yesPLoS ONE
Meningococcal vaccination in Chinese national immunization program (NIP) includes polysaccharide vaccine against Neisseria meningitidis serogroup A (MPV-A) and polysaccharide vaccine against Neisseria meningitidis serogroup A and C(MPV-AC).
Jianyong Shen   +3 more
doaj   +1 more source

Las vacunas conjugadas contra la enfermedad meningococica causadas por los serogrupos A, C, W-135, Y

open access: yesVacciMonitor, 2009
Review the current evidence on available and candidate quadrivalent meningococcal conjugate vaccines. Methods: A comprehensive overview of data on the currently available A-C-W135-Y meningococcal vaccine and the results of late stage development of novel
Marcos Aurelio P. Sáfadi
doaj  

Knowledge Levels and Attitudes of Pediatric Physicians Regarding Meningococcal Infections and Vaccines: A Cross-Sectional Study

open access: yesSüleyman Demirel Üniversitesi Tıp Fakültesi Dergisi
Objective: Invasive meningococcal disease (IMD) clinically manifests as meningitis, meningococcemia, or a combination of both. Globally, approximately 1.2 million meningococcal cases are reported annually, resulting in 135,000 deaths.
Hicran Altın
doaj   +1 more source

Home - About - Disclaimer - Privacy